Ironwood Pharmaceuticals, Inc. (IRWD)

NASDAQ: IRWD · Real-Time Price · USD

4.420

+0.190 (4.49%)

At close: Aug 3, 2026, 4:00 PM EDT

4.505

+0.085 (1.91%)

After-hours: Aug 3, 2026, 5:19 PM EDT

Ironwood Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	220.47	215.46	88.56	92.15	656.2	620.13
Cash & Short-Term Investments	220.47	215.46	88.56	92.15	656.2	620.13
Cash Growth	103.24%	143.29%	-3.90%	-85.96%	5.82%	71.04%
Accounts Receivable	105.84	46.75	81.89	129.12	115.46	114.04
Other Current Assets	5.98	11.98	11.92	12.01	8.97	11.05
Total Current Assets	332.29	274.18	182.37	233.29	780.63	745.23
Net Property, Plant & Equipment	12.06	12.75	15.52	18.17	20.31	22.93
Other Intangible Assets	1.84	2.04	2.86	3.68	283.66	-
Other Long-Term Assets	88.37	107.94	150.16	215.93	15.92	358.78
Total Assets	434.57	396.9	350.91	471.07	1,101	1,127

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	3.24	2.9	2.13	7.83	0.48	0.94
Accrued Expenses	29.95	36.39	33.53	65.59	21.96	39.46
Current Portion of Long-Term Debt	199.86	199.68	-	199.56	-	116.86
Current Portion of Leases	3.27	3.25	3.19	3.13	3.07	3.13
Other Current Liabilities	-	-	-	-	0.02	1.32
Total Current Liabilities	236.31	242.22	38.85	276.1	25.53	161.7
Long-Term Debt	385	385	583.99	498.31	396.25	337.33
Long-Term Leases	9.23	9.87	12.3	14.54	16.6	18.48
Other Long-Term Liabilities	21.17	21.65	17.11	28.42	9.77	3.5
Total Long-Term Liabilities	415.4	416.52	613.4	541.27	422.62	359.32
Total Liabilities	651.71	658.74	652.24	817.37	448.14	521.02

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.17	0.16	0.16	0.16	0.15	0.16
Additional Paid-in Capital	1,416	1,413	1,395	1,355	1,349	1,543
Accumulated Other Comprehensive Income	-0.8	-1.06	0.92	-3.03	-	-
Retained Earnings	-1,633	-1,674	-1,698	-1,699	-696.38	-937.61
Shareholders' Equity	-217.14	-261.84	-301.34	-346.3	652.38	605.91
Total Liabilities & Equity	434.57	396.9	350.91	471.07	1,101	1,127

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	597.36	597.8	599.48	715.54	415.92	475.8
Net Cash (Debt)	-376.89	-382.35	-510.92	-623.38	240.29	144.33
Net Cash Growth	-	-	-	-	66.49%	-
Net Cash Per Share	-2.21	-2.35	-3.19	-4.01	1.29	0.88
Book Value	-217.14	-261.84	-301.34	-346.3	652.38	605.91
Book Value Per Share	-1.27	-1.61	-1.88	-2.23	3.50	3.69
Tangible Book Value	-218.98	-263.88	-304.2	-349.98	368.72	605.91
Tangible Book Value Per Share	-1.28	-1.62	-1.90	-2.25	1.98	3.69

SEC Filings: 10-K · 10-Q